<- Go Home
The Oncology Institute, Inc.
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance services. The company also provides and manages clinical trials, palliative care programs, stem cell transplants services, other care delivery models associated with non-community-based academic, and tertiary care settings; and conducts clinical trials for a range of pharmaceutical, and medical device companies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Market Cap
$179.5M
Volume
702.0K
Cash and Equivalents
$39.7M
EBITDA
-$45.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$59.3M
Profit Margin
14.70%
52 Week High
$3.50
52 Week Low
$0.13
Dividend
N/A
Price / Book Value
41.58
Price / Earnings
-3.40
Price / Tangible Book Value
-13.01
Enterprise Value
$242.1M
Enterprise Value / EBITDA
-6.86
Operating Income
-$52.1M
Return on Equity
277.62%
Return on Assets
-17.66
Cash and Short Term Investments
$39.7M
Debt
$102.3M
Equity
$5.1M
Revenue
$403.2M
Unlevered FCF
$3.4M
Sector
Health Care Providers and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium